Building on its expertise in innovative biomedical ICT infrastructures for long-term cryo-preservation of biomaterial, Fraunhofer IBMT announced today that it is participating in a joint research initiative of thirteen European partners to develop the technologies to go beyond current state-of-the-art technologies in long term digital preservation.
The European Union funded initiative, called "ENSURE – Enabling kNowledge Sustainability, Usability and Recovery for Economic Value" will draw on actual use cases from health care, clinical trials, and financial services to focus on a large number of issues which have not fully addressed up until now, such as:
1. Securely leveraging a scalable pay-as-you go infrastructure.
2. Having businesses understand the economic implications of preservation.
3. Conforming to regulatory, contractual and legal requirements as part of a whole workflow
4. Managing long-term integrity and authenticity of significant intellectual property or highly personal data.
5. Using off-the-shelf ICT technologies for preservation to support different types of digital resources.
As the twenty first century progresses, our citizens and businesses are producing and receiving exponentially growing amounts of digital data. At the same time, technology keeps racing forward, with data formats being replaced and media form factors changing. Many of our commercially-oriented organizations are facing the serious problem of economically preserving a wide variety of data for future use, while ensuring protection of sensitive business data and privacy of individuals.
In a Storage Networking Industry Association survey over 80% of respondents had retention requirements over 50 years, and an IDC report predicted that by 2011, roughly 35% of information “might reasonably be expected to be stored for 10 years or more”. While past digital preservation efforts have focused on cultural heritage, there is a real, emerging need, driven by regulatory compliance and business value, for long-term digital preservation in more commercial-oriented sectors.
Funded for three years, and with an overall budget of over eleven million euro, ENSURE will introduce a breakthrough reference architecture for long-term digital preservation which is based around four main areas of innovation – evaluating cost and value for different digital preservation solutions, automation of the preservation lifecycle in a way which can integrate with organizations' existing workflow processes, content-aware long term data protection to address such issues as changes in personally identifiable information (PII), new and changing regulations, and obtaining a scalable solution by leveraging wider ICT innovations such as cloud technology.Fraunhofer IBMT is a leading technology developer for long-term cryo-preservation of biomaterial. The institute hosts several important bioarchives. Biobanks represent research resources of enormous value. However, this value can only be ensured if not only the quality of the biomaterial is maintained over the time but also the usability of the data that describe the characteristics of the biomaterial and its provenance and without them the biomaterial is worthless. Fraunhofer IBMT will contribute to this goal in ENSURE. Additionally it will research how formal ontologies can support long-term preservation in order to improve for example indexing of the domain specific digital objects and later searches and retrieval but also in order to describe preservation concepts and to trigger necessary transformations of digital objects to ensure their usability after decades. Fraunhofer IBMT will provide the respective semantic framework for ENSURE’s long-term preservation architecture. With its profound experience in developing innovative ICT solutions for biomedical research and for healthcare provision Fraunhofer IBMT will contribute to ensure that electronic health record data and clinical trial data but also data from the financial sector are securely ingested in the long-term preservation system and can be found and retrieved again after decades.
More information on ENSURE is available at www.ensure-fp7.euContact:
Scientists to give artificial intelligence human hearing
19.12.2018 | Peter the Great Saint-Petersburg Polytechnic University
German Research Foundation supports new theoretical physics project at Jacobs University Bremen
18.12.2018 | Jacobs University Bremen gGmbH
Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
19.12.2018 | Information Technology
19.12.2018 | Physics and Astronomy
19.12.2018 | Life Sciences